Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Wodka, US

Daniel M. Wodka, Chicago, IL US

Patent application numberDescriptionPublished
20100073890TORSION SPRING MECHANISM SUPPORTIVE OF A FLEXIBLE PRINTED CIRCUIT - Disclosed is a torsion spring mechanism that supports and guides a flexible printed circuit for use in an electronic device with a sliding motion. The spring mechanism includes a first segment and a second segment that are joined by a torsion spring. The torsion spring has a predetermined spring constant and is capable of exerting a force. When the force of the torsion spring is unreleased the sliding housing is closed and when the force of the torsion spring is released the sliding housing is opened. An electrically conducting flexible printed circuit is at least partially supported by both the first and second segments while freely traversing the torsion spring length with an unsupported portion enough to provide adequate movement of the flexible printed circuit about the torsion spring length. In this way, a spring compartment within the device being approximately 5 millimeters in depth may support and protect the unidirectional torsion spring mechanism and flexible printed circuit.03-25-2010

Dariusz Wodka, Whitetown, IN US

Patent application numberDescriptionPublished
20100222316INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME - The present invention relates to compounds which are inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme. The present invention further relates to the use of inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme for the treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, and other diseases and conditions that are mediated by excessive glucocorticoid action.09-02-2010

Dariusz Wodka, Monmouth Junction, NJ US

Patent application numberDescriptionPublished
20090054426TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS - A method for treating a patient suffering from disorders and deficits of the central nervous system associated with diabetes, associated with aging and neurodegeneration, comprising attention deficit disorder in general, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment, senile dementia, AIDS dementia, neurodegeneration, depression, and schizophrenia, comprising administering to a patient in need of such treatment an effective amount of a selective inhibitor of the 11-β-hydroxysteroid dehydrogenase Type 1 enzyme activity.02-26-2009
20090192141METHODS OF USE OF INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME - The present invention relates to inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.07-30-2009
20100081643NOVEL CYCLIC BENZIMIDAZOLE DERIVATIVES USEFUL AS ANTI-DIABETIC AGENTS - Novel compounds of the structural formula (I) are activators of AMP-protein kinase and are useful in the treatment, prevention and suppression of diseases mediated by the AMPK-activated protein kinase. The compounds of the present invention are useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension.04-01-2010
20100152179TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS - A method for treating a patient suffering from disorders and deficits of the central nervous system associated with diabetes, associated with aging and neurodegeneration, comprising attention deficit disorder in general, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment, senile dementia, AIDS dementia, neurodegeneration, depression, and schizophrenia, comprising administering to a patient in need of such treatment an effective amount of a selective inhibitor of the 11-β-hydroxysteroid dehydrogenase Type 1 enzyme activity.06-17-2010

Patent applications by Dariusz Wodka, Monmouth Junction, NJ US

Joseph F. Wodka, Hoffman Estates, IL US

Patent application numberDescriptionPublished
20080240010INTELLIGENT ORCHESTRATION OF CROSS-MEDIA COMMUNICATIONS - A method and architecture for managing a communication campaign direct toward a plurality of media consumption devices associated with a common user (10-02-2008
20080244660VIRTUAL SET-TOP BOX TUNER IN CONTENT DISTRIBUTION SYSTEM - A method for scheduling the reception of content in a content receiver, for example, in an STB/DVR, includes scheduling (10-02-2008
20090172745Method and Apparatus Regarding Receipt of Audio-Visual Content Information and Use of Such Information to Automatically Infer a Relative Popularity of That Content - A network element (07-02-2009

Patent applications by Joseph F. Wodka, Hoffman Estates, IL US

Joseph W. Wodka, Hoffman Estates, IL US

Patent application numberDescriptionPublished
20090241155Method and Apparatus to Facilitate Automatically Forming an Aggregation of Multiple Different Renderable Content Items - A network element (09-24-2009